Rank | Gene Set | Z-score |
---|---|---|
1 | lysine catabolic process (GO:0006554) | 6.22990109 |
2 | lysine metabolic process (GO:0006553) | 6.22990109 |
3 | tricarboxylic acid cycle (GO:0006099) | 5.48809366 |
4 | glyoxylate metabolic process (GO:0046487) | 5.22350722 |
5 | 2-oxoglutarate metabolic process (GO:0006103) | 5.09235177 |
6 | L-phenylalanine catabolic process (GO:0006559) | 5.05186390 |
7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.05186390 |
8 | L-phenylalanine metabolic process (GO:0006558) | 5.04814550 |
9 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.04814550 |
10 | aspartate family amino acid catabolic process (GO:0009068) | 4.94928610 |
11 | kynurenine metabolic process (GO:0070189) | 4.83512740 |
12 | nuclear pore complex assembly (GO:0051292) | 4.74474130 |
13 | aromatic amino acid family catabolic process (GO:0009074) | 4.64855042 |
14 | amino-acid betaine metabolic process (GO:0006577) | 4.57048003 |
15 | serine family amino acid catabolic process (GO:0009071) | 4.56139050 |
16 | glycine metabolic process (GO:0006544) | 4.54663715 |
17 | carnitine shuttle (GO:0006853) | 4.54423774 |
18 | fatty acid transmembrane transport (GO:1902001) | 4.53963752 |
19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.50152654 |
20 | ribosome assembly (GO:0042255) | 4.49480267 |
21 | nuclear pore organization (GO:0006999) | 4.48395252 |
22 | fatty acid beta-oxidation (GO:0006635) | 4.47814956 |
23 | acetyl-CoA metabolic process (GO:0006084) | 4.45102674 |
24 | cysteine metabolic process (GO:0006534) | 4.43618961 |
25 | alpha-linolenic acid metabolic process (GO:0036109) | 4.39192037 |
26 | cellular ketone body metabolic process (GO:0046950) | 4.37451683 |
27 | indole-containing compound catabolic process (GO:0042436) | 4.30362185 |
28 | indolalkylamine catabolic process (GO:0046218) | 4.30362185 |
29 | tryptophan catabolic process (GO:0006569) | 4.30362185 |
30 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.27074770 |
31 | oxaloacetate metabolic process (GO:0006107) | 4.21452957 |
32 | NADH metabolic process (GO:0006734) | 4.14056036 |
33 | carnitine metabolic process (GO:0009437) | 4.10399231 |
34 | branched-chain amino acid catabolic process (GO:0009083) | 4.09918362 |
35 | serine family amino acid metabolic process (GO:0009069) | 4.05977713 |
36 | bile acid biosynthetic process (GO:0006699) | 4.05407950 |
37 | tryptophan metabolic process (GO:0006568) | 4.04790813 |
38 | fatty acid oxidation (GO:0019395) | 4.04753457 |
39 | urea cycle (GO:0000050) | 4.02952653 |
40 | urea metabolic process (GO:0019627) | 4.02952653 |
41 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.02383219 |
42 | alpha-amino acid catabolic process (GO:1901606) | 4.02000040 |
43 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.98211156 |
44 | valine metabolic process (GO:0006573) | 3.98065839 |
45 | lipid oxidation (GO:0034440) | 3.97331883 |
46 | serine family amino acid biosynthetic process (GO:0009070) | 3.95415999 |
47 | homocysteine metabolic process (GO:0050667) | 3.95112274 |
48 | fatty acid catabolic process (GO:0009062) | 3.90913328 |
49 | tricarboxylic acid metabolic process (GO:0072350) | 3.90622441 |
50 | short-chain fatty acid metabolic process (GO:0046459) | 3.87491097 |
51 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.86593002 |
52 | ketone body metabolic process (GO:1902224) | 3.85963055 |
53 | branched-chain amino acid metabolic process (GO:0009081) | 3.83608652 |
54 | sulfur amino acid catabolic process (GO:0000098) | 3.81064987 |
55 | regulation of triglyceride catabolic process (GO:0010896) | 3.78835510 |
56 | cellular amino acid catabolic process (GO:0009063) | 3.75381923 |
57 | succinate metabolic process (GO:0006105) | 3.75301097 |
58 | complement activation, alternative pathway (GO:0006957) | 3.74538416 |
59 | monocarboxylic acid catabolic process (GO:0072329) | 3.69144015 |
60 | regulation of sequestering of triglyceride (GO:0010889) | 3.67428533 |
61 | nitrogen cycle metabolic process (GO:0071941) | 3.66688266 |
62 | pore complex assembly (GO:0046931) | 3.65578364 |
63 | regulation of protein activation cascade (GO:2000257) | 3.64243045 |
64 | mitochondrial RNA metabolic process (GO:0000959) | 3.63621116 |
65 | sarcomere organization (GO:0045214) | 3.62017773 |
66 | ethanol oxidation (GO:0006069) | 3.60614697 |
67 | amino-acid betaine transport (GO:0015838) | 3.55957385 |
68 | carnitine transport (GO:0015879) | 3.55957385 |
69 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.55943311 |
70 | carnitine transmembrane transport (GO:1902603) | 3.55274450 |
71 | COPII vesicle coating (GO:0048208) | 3.53509773 |
72 | organic acid catabolic process (GO:0016054) | 3.53036054 |
73 | carboxylic acid catabolic process (GO:0046395) | 3.53036054 |
74 | biotin metabolic process (GO:0006768) | 3.52882906 |
75 | negative regulation of fibrinolysis (GO:0051918) | 3.52573489 |
76 | regulation of centriole replication (GO:0046599) | 3.49391445 |
77 | aromatic amino acid family metabolic process (GO:0009072) | 3.47065802 |
78 | cardiac myofibril assembly (GO:0055003) | 3.46808836 |
79 | glutamate metabolic process (GO:0006536) | 3.46578744 |
80 | regulation of fatty acid oxidation (GO:0046320) | 3.45194422 |
81 | fatty acid homeostasis (GO:0055089) | 3.45081427 |
82 | cellular modified amino acid catabolic process (GO:0042219) | 3.44841729 |
83 | regulation of complement activation (GO:0030449) | 3.44260654 |
84 | protein carboxylation (GO:0018214) | 3.44251985 |
85 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.44251985 |
86 | oxidative phosphorylation (GO:0006119) | 3.43547793 |
87 | regulation of coenzyme metabolic process (GO:0051196) | 3.43361708 |
88 | regulation of cofactor metabolic process (GO:0051193) | 3.43361708 |
89 | tRNA aminoacylation for protein translation (GO:0006418) | 3.42756014 |
90 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.42122054 |
91 | amino acid activation (GO:0043038) | 3.40210367 |
92 | tRNA aminoacylation (GO:0043039) | 3.40210367 |
93 | mitotic sister chromatid cohesion (GO:0007064) | 3.36979311 |
94 | bile acid metabolic process (GO:0008206) | 3.33195367 |
95 | high-density lipoprotein particle remodeling (GO:0034375) | 3.30600527 |
96 | dicarboxylic acid metabolic process (GO:0043648) | 3.28379725 |
97 | coenzyme catabolic process (GO:0009109) | 3.27401208 |
98 | acylglycerol homeostasis (GO:0055090) | 3.26640604 |
99 | triglyceride homeostasis (GO:0070328) | 3.26640604 |
100 | positive regulation of fatty acid oxidation (GO:0046321) | 3.22748150 |
101 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.20622826 |
102 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.19966697 |
103 | phospholipid homeostasis (GO:0055091) | 3.19344667 |
104 | muscle filament sliding (GO:0030049) | 3.18384602 |
105 | actin-myosin filament sliding (GO:0033275) | 3.18384602 |
106 | tyrosine metabolic process (GO:0006570) | 3.16487413 |
107 | DNA double-strand break processing (GO:0000729) | 3.15689043 |
108 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.15037389 |
109 | regulation of translational fidelity (GO:0006450) | 3.14898690 |
110 | quaternary ammonium group transport (GO:0015697) | 3.13716118 |
111 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.13681573 |
112 | regulation of fibrinolysis (GO:0051917) | 3.13134968 |
113 | imidazole-containing compound metabolic process (GO:0052803) | 3.12276999 |
114 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.12192283 |
115 | NAD metabolic process (GO:0019674) | 3.11450405 |
116 | maturation of 5.8S rRNA (GO:0000460) | 3.09902949 |
117 | L-serine metabolic process (GO:0006563) | 3.09647960 |
118 | mitotic nuclear envelope disassembly (GO:0007077) | 3.09440975 |
119 | pseudouridine synthesis (GO:0001522) | 3.02630107 |
120 | DNA strand elongation (GO:0022616) | 3.00728431 |
121 | meiotic chromosome segregation (GO:0045132) | 2.99880684 |
122 | regulation of DNA endoreduplication (GO:0032875) | 2.99501983 |
123 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.96734526 |
124 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.96734526 |
125 | proteasome assembly (GO:0043248) | 2.95519766 |
126 | IMP biosynthetic process (GO:0006188) | 2.93920984 |
127 | ubiquinone biosynthetic process (GO:0006744) | 2.92463348 |
128 | ER overload response (GO:0006983) | 2.91758065 |
129 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.88024807 |
130 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.88024807 |
131 | transcription from mitochondrial promoter (GO:0006390) | 2.87679965 |
132 | nucleobase biosynthetic process (GO:0046112) | 2.87400404 |
133 | non-recombinational repair (GO:0000726) | 2.86123522 |
134 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.86123522 |
135 | replication fork processing (GO:0031297) | 2.86119905 |
136 | membrane disassembly (GO:0030397) | 2.85939265 |
137 | nuclear envelope disassembly (GO:0051081) | 2.85939265 |
138 | IMP metabolic process (GO:0046040) | 2.84653309 |
139 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.83792213 |
140 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.83054526 |
141 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.82940399 |
142 | postreplication repair (GO:0006301) | 2.82640607 |
143 | ribosome biogenesis (GO:0042254) | 2.82547041 |
144 | methionine biosynthetic process (GO:0009086) | 2.82374599 |
145 | regulation of centrosome cycle (GO:0046605) | 2.81415296 |
146 | folic acid metabolic process (GO:0046655) | 2.79689274 |
147 | regulation of centrosome duplication (GO:0010824) | 2.76877202 |
148 | purine nucleobase biosynthetic process (GO:0009113) | 2.76145001 |
149 | protein K6-linked ubiquitination (GO:0085020) | 2.72666114 |
150 | ubiquinone metabolic process (GO:0006743) | 2.72562252 |
151 | regulation of translational elongation (GO:0006448) | 2.71113866 |
152 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.68804147 |
153 | tRNA methylation (GO:0030488) | 2.68034958 |
154 | tetrahydrofolate metabolic process (GO:0046653) | 2.67755133 |
155 | DNA geometric change (GO:0032392) | 2.66491913 |
156 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.65028300 |
157 | DNA replication initiation (GO:0006270) | 2.64532874 |
158 | DNA duplex unwinding (GO:0032508) | 2.62198868 |
159 | protein deneddylation (GO:0000338) | 2.61998574 |
160 | cullin deneddylation (GO:0010388) | 2.61932052 |
161 | histone H2A acetylation (GO:0043968) | 2.61269963 |
162 | mitotic chromosome condensation (GO:0007076) | 2.60992626 |
163 | tRNA metabolic process (GO:0006399) | 2.58954953 |
164 | synapsis (GO:0007129) | 2.58062616 |
165 | sulfur amino acid biosynthetic process (GO:0000097) | 2.57838320 |
166 | DNA unwinding involved in DNA replication (GO:0006268) | 2.57360442 |
167 | formation of translation preinitiation complex (GO:0001731) | 2.55321410 |
168 | telomere maintenance via recombination (GO:0000722) | 2.53460266 |
169 | L-methionine salvage (GO:0071267) | 2.52776183 |
170 | L-methionine biosynthetic process (GO:0071265) | 2.52776183 |
171 | amino acid salvage (GO:0043102) | 2.52776183 |
172 | regulation of glucokinase activity (GO:0033131) | 2.51670677 |
173 | regulation of hexokinase activity (GO:1903299) | 2.51670677 |
174 | translesion synthesis (GO:0019985) | 2.51184174 |
175 | methionine metabolic process (GO:0006555) | 2.50993137 |
176 | folic acid-containing compound metabolic process (GO:0006760) | 2.50052866 |
177 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.49609692 |
178 | isotype switching (GO:0045190) | 2.49609692 |
179 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.49609692 |
180 | rRNA catabolic process (GO:0016075) | 2.49457276 |
181 | regulation of sister chromatid cohesion (GO:0007063) | 2.49338849 |
182 | DNA catabolic process, exonucleolytic (GO:0000738) | 2.48980974 |
183 | respiratory chain complex IV assembly (GO:0008535) | 2.48866430 |
184 | ribonucleoprotein complex disassembly (GO:0032988) | 2.47689021 |
185 | DNA replication checkpoint (GO:0000076) | 2.47265181 |
186 | mitotic sister chromatid segregation (GO:0000070) | 2.45957589 |
187 | mitochondrial DNA replication (GO:0006264) | 2.45409832 |
188 | regulation of relaxation of muscle (GO:1901077) | 2.44980075 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.35490737 |
2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.41921494 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.48296611 |
4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.10252160 |
5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.17671915 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.03741846 |
7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.53720167 |
8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.51495067 |
9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.39685841 |
10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.14239613 |
11 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.94104306 |
12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.74294221 |
13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.73608896 |
14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.64119692 |
15 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.63944696 |
16 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 2.58906223 |
17 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.26920958 |
18 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.21192804 |
19 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.21102144 |
20 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.15920867 |
21 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.15149021 |
22 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.10964652 |
23 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 2.10868008 |
24 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.08316925 |
25 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.94673325 |
26 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.93150879 |
27 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.83990756 |
28 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.83480245 |
29 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.77537558 |
30 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.76246950 |
31 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.71519202 |
32 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.66350544 |
33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.62875588 |
34 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.62074168 |
35 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.58439104 |
36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.52570449 |
37 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.49495798 |
38 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.45127680 |
39 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.44390236 |
40 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.42052369 |
41 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.40466116 |
42 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.39823691 |
43 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.37568689 |
44 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.37426608 |
45 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.36974291 |
46 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.35926360 |
47 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.34206988 |
48 | * TTF2_22483619_ChIP-Seq_HELA_Human | 1.33922879 |
49 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33260872 |
50 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33240858 |
51 | FUS_26573619_Chip-Seq_HEK293_Human | 1.32847239 |
52 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.32266292 |
53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32151742 |
54 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.31918746 |
55 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.31663989 |
56 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.30808928 |
57 | EWS_26573619_Chip-Seq_HEK293_Human | 1.30521906 |
58 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.29535653 |
59 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.26966796 |
60 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.24259729 |
61 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.19877242 |
62 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.19000994 |
63 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18744480 |
64 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.18652534 |
65 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.17796487 |
66 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.15831806 |
67 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.15500582 |
68 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.15004658 |
69 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.14590461 |
70 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.14590461 |
71 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.12254910 |
72 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10263959 |
73 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.09278790 |
74 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.07772695 |
75 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.07704300 |
76 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.06088230 |
77 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.06077862 |
78 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.05704746 |
79 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05587445 |
80 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.04037145 |
81 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.02742616 |
82 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.01890898 |
83 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.01848195 |
84 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.01122172 |
85 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.01102721 |
86 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.00686693 |
87 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98665630 |
88 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.98495011 |
89 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.97838409 |
90 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.95987287 |
91 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.95290064 |
92 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.95137373 |
93 | ATF3_27146783_Chip-Seq_COLON_Human | 0.95030106 |
94 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95012388 |
95 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.94659728 |
96 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.94591478 |
97 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.94264735 |
98 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.93077403 |
99 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.92877434 |
100 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.92809172 |
101 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.92723928 |
102 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.92291672 |
103 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.92170378 |
104 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.89209061 |
105 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.86069074 |
106 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.85912291 |
107 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.85872944 |
108 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.84990670 |
109 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.83354290 |
110 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.82344688 |
111 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.81656246 |
112 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81404783 |
113 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.80699865 |
114 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.79162841 |
115 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.79096969 |
116 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.78983689 |
117 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.78904593 |
118 | * TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.78426553 |
119 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.77391098 |
120 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.77258819 |
121 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.76202204 |
122 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.76193846 |
123 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.76071671 |
124 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.75985157 |
125 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.75674098 |
126 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.75617129 |
127 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.75476861 |
128 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.72678718 |
129 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.72333999 |
130 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.71769753 |
131 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.71315756 |
132 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.70980749 |
133 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.70977215 |
134 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.69731771 |
135 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.69638795 |
136 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.69078803 |
137 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.67535701 |
138 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.67406668 |
139 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.67125931 |
140 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.66816060 |
141 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.66571084 |
142 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66517096 |
143 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.65766186 |
144 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.64333575 |
145 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.64265471 |
146 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.64041255 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 5.49952387 |
2 | MP0002139_abnormal_hepatobiliary_system | 5.48971035 |
3 | MP0003806_abnormal_nucleotide_metabolis | 4.60847835 |
4 | MP0005085_abnormal_gallbladder_physiolo | 4.56800919 |
5 | MP0008057_abnormal_DNA_replication | 4.22932941 |
6 | MP0005365_abnormal_bile_salt | 4.03407751 |
7 | MP0002837_dystrophic_cardiac_calcinosis | 3.53022048 |
8 | MP0003646_muscle_fatigue | 3.49633912 |
9 | MP0010094_abnormal_chromosome_stability | 3.47907425 |
10 | MP0008058_abnormal_DNA_repair | 3.34313665 |
11 | MP0004084_abnormal_cardiac_muscle | 3.12604915 |
12 | MP0008875_abnormal_xenobiotic_pharmacok | 3.05485144 |
13 | MP0010234_abnormal_vibrissa_follicle | 3.05218922 |
14 | MP0003252_abnormal_bile_duct | 2.63845500 |
15 | MP0005332_abnormal_amino_acid | 2.57671533 |
16 | MP0010329_abnormal_lipoprotein_level | 2.43282910 |
17 | MP0005330_cardiomyopathy | 2.42832447 |
18 | MP0004036_abnormal_muscle_relaxation | 2.35170363 |
19 | MP0004215_abnormal_myocardial_fiber | 2.34003324 |
20 | MP0000749_muscle_degeneration | 2.33300634 |
21 | MP0009840_abnormal_foam_cell | 2.30201331 |
22 | MP0003111_abnormal_nucleus_morphology | 2.29639808 |
23 | MP0006036_abnormal_mitochondrial_physio | 2.27181420 |
24 | MP0000751_myopathy | 2.23920042 |
25 | MP0005083_abnormal_biliary_tract | 2.13735027 |
26 | MP0004130_abnormal_muscle_cell | 2.08583101 |
27 | MP0003195_calcinosis | 1.99245535 |
28 | MP0003077_abnormal_cell_cycle | 1.95981219 |
29 | MP0003705_abnormal_hypodermis_morpholog | 1.89815289 |
30 | MP0008007_abnormal_cellular_replicative | 1.87599843 |
31 | MP0002269_muscular_atrophy | 1.85138485 |
32 | MP0001661_extended_life_span | 1.83734545 |
33 | MP0004087_abnormal_muscle_fiber | 1.83603908 |
34 | MP0002877_abnormal_melanocyte_morpholog | 1.81974561 |
35 | MP0005319_abnormal_enzyme/_coenzyme | 1.81234881 |
36 | MP0008775_abnormal_heart_ventricle | 1.77099942 |
37 | MP0005187_abnormal_penis_morphology | 1.75079703 |
38 | MP0003221_abnormal_cardiomyocyte_apopto | 1.71476784 |
39 | MP0002009_preneoplasia | 1.68897409 |
40 | MP0002972_abnormal_cardiac_muscle | 1.65941133 |
41 | MP0000609_abnormal_liver_physiology | 1.63909745 |
42 | MP0003186_abnormal_redox_activity | 1.58340223 |
43 | MP0002118_abnormal_lipid_homeostasis | 1.58010077 |
44 | MP0006035_abnormal_mitochondrial_morpho | 1.56846912 |
45 | MP0008932_abnormal_embryonic_tissue | 1.56827023 |
46 | MP0001666_abnormal_nutrient_absorption | 1.54905407 |
47 | MP0010630_abnormal_cardiac_muscle | 1.54686249 |
48 | MP0001544_abnormal_cardiovascular_syste | 1.53974920 |
49 | MP0005385_cardiovascular_system_phenoty | 1.53974920 |
50 | MP0000372_irregular_coat_pigmentation | 1.51673433 |
51 | MP0005620_abnormal_muscle_contractility | 1.46268902 |
52 | MP0010678_abnormal_skin_adnexa | 1.45529289 |
53 | MP0005645_abnormal_hypothalamus_physiol | 1.44230123 |
54 | MP0006138_congestive_heart_failure | 1.43766254 |
55 | MP0008877_abnormal_DNA_methylation | 1.43716369 |
56 | MP0005670_abnormal_white_adipose | 1.40043867 |
57 | MP0000013_abnormal_adipose_tissue | 1.38352559 |
58 | MP0000647_abnormal_sebaceous_gland | 1.37750721 |
59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.36997974 |
60 | MP0005666_abnormal_adipose_tissue | 1.34565673 |
61 | MP0000747_muscle_weakness | 1.32368114 |
62 | MP0000750_abnormal_muscle_regeneration | 1.31605464 |
63 | MP0005266_abnormal_metabolism | 1.30172588 |
64 | MP0003191_abnormal_cellular_cholesterol | 1.27151549 |
65 | MP0003786_premature_aging | 1.27147067 |
66 | MP0005451_abnormal_body_composition | 1.27082334 |
67 | MP0009643_abnormal_urine_homeostasis | 1.25582460 |
68 | MP0003137_abnormal_impulse_conducting | 1.25179748 |
69 | MP0004019_abnormal_vitamin_homeostasis | 1.22069275 |
70 | MP0002106_abnormal_muscle_physiology | 1.21273219 |
71 | MP0001764_abnormal_homeostasis | 1.20700875 |
72 | MP0000427_abnormal_hair_cycle | 1.19467623 |
73 | MP0003941_abnormal_skin_development | 1.18941090 |
74 | MP0003656_abnormal_erythrocyte_physiolo | 1.18592052 |
75 | MP0009697_abnormal_copulation | 1.18517219 |
76 | MP0002138_abnormal_hepatobiliary_system | 1.13558568 |
77 | MP0005248_abnormal_Harderian_gland | 1.10891485 |
78 | MP0006072_abnormal_retinal_apoptosis | 1.10804325 |
79 | MP0000358_abnormal_cell_content/ | 1.09740869 |
80 | MP0002095_abnormal_skin_pigmentation | 1.09192707 |
81 | MP0000598_abnormal_liver_morphology | 1.06534174 |
82 | MP0000383_abnormal_hair_follicle | 1.02282609 |
83 | MP0004233_abnormal_muscle_weight | 1.02000034 |
84 | MP0000759_abnormal_skeletal_muscle | 1.01051769 |
85 | MP0005379_endocrine/exocrine_gland_phen | 1.00132435 |
86 | MP0002332_abnormal_exercise_endurance | 1.00052920 |
87 | MP0002971_abnormal_brown_adipose | 0.99514504 |
88 | MP0010307_abnormal_tumor_latency | 0.97445499 |
89 | MP0009780_abnormal_chondrocyte_physiolo | 0.96368770 |
90 | MP0000569_abnormal_digit_pigmentation | 0.95461489 |
91 | MP0002127_abnormal_cardiovascular_syste | 0.94177959 |
92 | MP0004484_altered_response_of | 0.93125900 |
93 | MP0003567_abnormal_fetal_cardiomyocyte | 0.92886517 |
94 | MP0005369_muscle_phenotype | 0.90590265 |
95 | MP0000015_abnormal_ear_pigmentation | 0.90012871 |
96 | MP0002098_abnormal_vibrissa_morphology | 0.89264305 |
97 | MP0002396_abnormal_hematopoietic_system | 0.87214171 |
98 | MP0000350_abnormal_cell_proliferation | 0.86413789 |
99 | MP0001697_abnormal_embryo_size | 0.83712951 |
100 | MP0004043_abnormal_pH_regulation | 0.83040622 |
101 | MP0003868_abnormal_feces_composition | 0.82573684 |
102 | MP0004085_abnormal_heartbeat | 0.81443000 |
103 | MP0002078_abnormal_glucose_homeostasis | 0.81129655 |
104 | MP0004185_abnormal_adipocyte_glucose | 0.81007292 |
105 | MP0005376_homeostasis/metabolism_phenot | 0.80879120 |
106 | MP0001727_abnormal_embryo_implantation | 0.80295259 |
107 | MP0005171_absent_coat_pigmentation | 0.79677784 |
108 | MP0004134_abnormal_chest_morphology | 0.79214605 |
109 | MP0002080_prenatal_lethality | 0.79167115 |
110 | MP0005075_abnormal_melanosome_morpholog | 0.79161682 |
111 | MP0005253_abnormal_eye_physiology | 0.78915570 |
112 | MP0004197_abnormal_fetal_growth/weight/ | 0.78257296 |
113 | MP0000627_abnormal_mammary_gland | 0.77620879 |
114 | MP0000377_abnormal_hair_follicle | 0.77028963 |
115 | MP0001730_embryonic_growth_arrest | 0.76455757 |
116 | MP0009763_increased_sensitivity_to | 0.75402821 |
117 | MP0000003_abnormal_adipose_tissue | 0.74373246 |
118 | MP0003984_embryonic_growth_retardation | 0.72645499 |
119 | MP0004145_abnormal_muscle_electrophysio | 0.72534079 |
120 | MP0004147_increased_porphyrin_level | 0.72485219 |
121 | MP0009672_abnormal_birth_weight | 0.72469593 |
122 | MP0009046_muscle_twitch | 0.72132434 |
123 | MP0002090_abnormal_vision | 0.71744825 |
124 | MP0001756_abnormal_urination | 0.71676033 |
125 | MP0002088_abnormal_embryonic_growth/wei | 0.71360993 |
126 | MP0003828_pulmonary_edema | 0.70708236 |
127 | MP0003566_abnormal_cell_adhesion | 0.70675060 |
128 | MP0005220_abnormal_exocrine_pancreas | 0.69963082 |
129 | MP0010368_abnormal_lymphatic_system | 0.69674858 |
130 | MP0000266_abnormal_heart_morphology | 0.68922277 |
131 | MP0002160_abnormal_reproductive_system | 0.68915577 |
132 | MP0004782_abnormal_surfactant_physiolog | 0.68243448 |
133 | MP0002086_abnormal_extraembryonic_tissu | 0.66708392 |
134 | MP0001929_abnormal_gametogenesis | 0.66326235 |
135 | MP0003718_maternal_effect | 0.66209482 |
136 | MP0005636_abnormal_mineral_homeostasis | 0.65591468 |
137 | MP0005375_adipose_tissue_phenotype | 0.64701343 |
138 | MP0010352_gastrointestinal_tract_polyps | 0.63047060 |
139 | MP0001672_abnormal_embryogenesis/_devel | 0.62752904 |
140 | MP0005380_embryogenesis_phenotype | 0.62752904 |
141 | MP0009642_abnormal_blood_homeostasis | 0.62536163 |
142 | MP0003950_abnormal_plasma_membrane | 0.61853454 |
143 | MP0005334_abnormal_fat_pad | 0.60257118 |
144 | MP0000343_altered_response_to | 0.58946038 |
145 | MP0005647_abnormal_sex_gland | 0.58876524 |
146 | MP0004957_abnormal_blastocyst_morpholog | 0.58138256 |
147 | MP0003693_abnormal_embryo_hatching | 0.56108057 |
148 | MP0005535_abnormal_body_temperature | 0.55837467 |
149 | MP0002970_abnormal_white_adipose | 0.54935121 |
150 | MP0005165_increased_susceptibility_to | 0.54877050 |
151 | MP0002128_abnormal_blood_circulation | 0.54349940 |
152 | MP0000230_abnormal_systemic_arterial | 0.54102446 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hyperammonemia (HP:0001987) | 4.59846394 |
2 | Hyperglycinuria (HP:0003108) | 4.58940581 |
3 | Hypoglycemic coma (HP:0001325) | 4.48897992 |
4 | Intrahepatic cholestasis (HP:0001406) | 4.43479963 |
5 | Myoglobinuria (HP:0002913) | 4.40509977 |
6 | Exercise-induced muscle cramps (HP:0003710) | 4.27117285 |
7 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.21417025 |
8 | Abnormality of glycine metabolism (HP:0010895) | 4.21417025 |
9 | Ketosis (HP:0001946) | 4.16787670 |
10 | Deep venous thrombosis (HP:0002625) | 4.12093887 |
11 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.04765303 |
12 | Hyperglycinemia (HP:0002154) | 4.02359901 |
13 | Rhabdomyolysis (HP:0003201) | 4.00668676 |
14 | Hypobetalipoproteinemia (HP:0003563) | 3.99323412 |
15 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.98765118 |
16 | Ketoacidosis (HP:0001993) | 3.96601019 |
17 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.93245457 |
18 | Nemaline bodies (HP:0003798) | 3.88085258 |
19 | Xanthomatosis (HP:0000991) | 3.88008702 |
20 | Muscle fiber inclusion bodies (HP:0100299) | 3.85933054 |
21 | Sudden death (HP:0001699) | 3.81381292 |
22 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.73877715 |
23 | Dicarboxylic aciduria (HP:0003215) | 3.65140976 |
24 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.65140976 |
25 | Exercise-induced myalgia (HP:0003738) | 3.53369095 |
26 | Hypolipoproteinemia (HP:0010981) | 3.53247879 |
27 | Ventricular tachycardia (HP:0004756) | 3.47198992 |
28 | Hypoalphalipoproteinemia (HP:0003233) | 3.44463083 |
29 | Cerebral edema (HP:0002181) | 3.40754861 |
30 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.25946431 |
31 | Abnormality of serum amino acid levels (HP:0003112) | 3.23201822 |
32 | Hyperlipoproteinemia (HP:0010980) | 3.16039592 |
33 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.11128000 |
34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.10034114 |
35 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.08413220 |
36 | Hepatic necrosis (HP:0002605) | 3.05806218 |
37 | Lethargy (HP:0001254) | 3.00838996 |
38 | Abnormality of methionine metabolism (HP:0010901) | 3.00585260 |
39 | Right ventricular cardiomyopathy (HP:0011663) | 2.97499249 |
40 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.96901117 |
41 | Microvesicular hepatic steatosis (HP:0001414) | 2.95791194 |
42 | Complement deficiency (HP:0004431) | 2.94196714 |
43 | Calf muscle hypertrophy (HP:0008981) | 2.91923231 |
44 | Palpitations (HP:0001962) | 2.88449707 |
45 | Lipid accumulation in hepatocytes (HP:0006561) | 2.87167423 |
46 | Nausea (HP:0002018) | 2.86387750 |
47 | Generalized aminoaciduria (HP:0002909) | 2.86038892 |
48 | Progressive muscle weakness (HP:0003323) | 2.85642078 |
49 | Prolonged partial thromboplastin time (HP:0003645) | 2.85166682 |
50 | Abnormality of glycolysis (HP:0004366) | 2.83008288 |
51 | Increased serum pyruvate (HP:0003542) | 2.83008288 |
52 | Lipoatrophy (HP:0100578) | 2.82572622 |
53 | * Metabolic acidosis (HP:0001942) | 2.81909573 |
54 | Glioma (HP:0009733) | 2.79004958 |
55 | Proximal tubulopathy (HP:0000114) | 2.72417844 |
56 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.70028180 |
57 | Epidermoid cyst (HP:0200040) | 2.68465848 |
58 | Acute encephalopathy (HP:0006846) | 2.67306882 |
59 | Gout (HP:0001997) | 2.66177834 |
60 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.62310557 |
61 | Ragged-red muscle fibers (HP:0003200) | 2.62294856 |
62 | Cholelithiasis (HP:0001081) | 2.60131727 |
63 | Increased hepatocellular lipid droplets (HP:0006565) | 2.58771630 |
64 | Pheochromocytoma (HP:0002666) | 2.58331763 |
65 | Hyporeflexia of lower limbs (HP:0002600) | 2.58275976 |
66 | Increased muscle lipid content (HP:0009058) | 2.56209519 |
67 | Muscle fiber splitting (HP:0003555) | 2.53763216 |
68 | Increased connective tissue (HP:0009025) | 2.52114070 |
69 | Atrial fibrillation (HP:0005110) | 2.51365777 |
70 | Dilated cardiomyopathy (HP:0001644) | 2.51334849 |
71 | Neuroendocrine neoplasm (HP:0100634) | 2.48944680 |
72 | Neoplasm of the adrenal gland (HP:0100631) | 2.47171494 |
73 | Abnormality of nucleobase metabolism (HP:0010932) | 2.46559087 |
74 | Abnormal gallbladder morphology (HP:0012437) | 2.43672539 |
75 | Skin nodule (HP:0200036) | 2.41200838 |
76 | Chromsome breakage (HP:0040012) | 2.38187603 |
77 | Lactic acidosis (HP:0003128) | 2.37323504 |
78 | Hyperbilirubinemia (HP:0002904) | 2.37195044 |
79 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.36967793 |
80 | Medulloblastoma (HP:0002885) | 2.36856569 |
81 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.36227241 |
82 | Abnormal protein glycosylation (HP:0012346) | 2.36227241 |
83 | Abnormal glycosylation (HP:0012345) | 2.36227241 |
84 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.36227241 |
85 | Vomiting (HP:0002013) | 2.36081090 |
86 | Conjunctival hamartoma (HP:0100780) | 2.35717156 |
87 | Abnormality of the astrocytes (HP:0100707) | 2.35385593 |
88 | Astrocytoma (HP:0009592) | 2.35385593 |
89 | Abnormality of purine metabolism (HP:0004352) | 2.34824540 |
90 | Delayed CNS myelination (HP:0002188) | 2.34320274 |
91 | Reduced antithrombin III activity (HP:0001976) | 2.32006434 |
92 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.30173102 |
93 | Fat malabsorption (HP:0002630) | 2.29898924 |
94 | Type I transferrin isoform profile (HP:0003642) | 2.28245735 |
95 | Papillary thyroid carcinoma (HP:0002895) | 2.26883854 |
96 | Hepatocellular necrosis (HP:0001404) | 2.26857960 |
97 | Primary atrial arrhythmia (HP:0001692) | 2.25512362 |
98 | Abnormality of the common coagulation pathway (HP:0010990) | 2.24836867 |
99 | Abnormality of the calf musculature (HP:0001430) | 2.24110350 |
100 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.21998292 |
101 | Subaortic stenosis (HP:0001682) | 2.21998292 |
102 | * Increased serum lactate (HP:0002151) | 2.21816471 |
103 | Renal cortical cysts (HP:0000803) | 2.20969806 |
104 | Supraventricular tachycardia (HP:0004755) | 2.20800399 |
105 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.20473253 |
106 | Abnormality of alanine metabolism (HP:0010916) | 2.20473253 |
107 | Hyperalaninemia (HP:0003348) | 2.20473253 |
108 | Abnormality of complement system (HP:0005339) | 2.20397324 |
109 | Hepatocellular carcinoma (HP:0001402) | 2.18905223 |
110 | Abnormality of chromosome stability (HP:0003220) | 2.18236350 |
111 | EMG: myopathic abnormalities (HP:0003458) | 2.17683397 |
112 | Rimmed vacuoles (HP:0003805) | 2.17519134 |
113 | Hyperglycemia (HP:0003074) | 2.17232842 |
114 | Increased purine levels (HP:0004368) | 2.16945810 |
115 | Hyperuricemia (HP:0002149) | 2.16945810 |
116 | Asymmetric septal hypertrophy (HP:0001670) | 2.16945410 |
117 | Supraventricular arrhythmia (HP:0005115) | 2.16023991 |
118 | Atrioventricular block (HP:0001678) | 2.15664082 |
119 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.12106145 |
120 | Increased intramyocellular lipid droplets (HP:0012240) | 2.10660252 |
121 | Acute necrotizing encephalopathy (HP:0006965) | 2.09953267 |
122 | Abnormal gallbladder physiology (HP:0012438) | 2.09670200 |
123 | Cholecystitis (HP:0001082) | 2.09670200 |
124 | Syncope (HP:0001279) | 2.09259494 |
125 | Abnormality of urine glucose concentration (HP:0011016) | 2.09151377 |
126 | Glycosuria (HP:0003076) | 2.09151377 |
127 | Abnormality of the intrinsic pathway (HP:0010989) | 2.07911281 |
128 | * Increased CSF lactate (HP:0002490) | 2.07357920 |
129 | Neoplasm of the peripheral nervous system (HP:0100007) | 2.04203919 |
130 | Volvulus (HP:0002580) | 1.99245740 |
131 | Bundle branch block (HP:0011710) | 1.96111484 |
132 | Exercise intolerance (HP:0003546) | 1.95373040 |
133 | Hypoplasia of the pons (HP:0012110) | 1.90073382 |
134 | Neoplasm of the small intestine (HP:0100833) | 1.89498639 |
135 | Colon cancer (HP:0003003) | 1.84720499 |
136 | Progressive inability to walk (HP:0002505) | 1.82283408 |
137 | Neoplasm of the adrenal cortex (HP:0100641) | 1.81899666 |
138 | Horizontal nystagmus (HP:0000666) | 1.80895906 |
139 | Thyroid carcinoma (HP:0002890) | 1.80141093 |
140 | Abnormality of the pons (HP:0007361) | 1.79272441 |
141 | Abnormality of the renal cortex (HP:0011035) | 1.78799251 |
142 | Cerebellar dysplasia (HP:0007033) | 1.76690673 |
143 | Shoulder girdle muscle weakness (HP:0003547) | 1.76164238 |
144 | Type II lissencephaly (HP:0007260) | 1.75959204 |
145 | Entropion (HP:0000621) | 1.70999631 |
146 | CNS demyelination (HP:0007305) | 1.69575271 |
147 | Methylmalonic acidemia (HP:0002912) | 1.69133103 |
148 | Patchy hypopigmentation of hair (HP:0011365) | 1.68741009 |
149 | Progressive macrocephaly (HP:0004481) | 1.68708263 |
150 | Insidious onset (HP:0003587) | 1.66217245 |
151 | Termporal pattern (HP:0011008) | 1.66217245 |
152 | Degeneration of anterior horn cells (HP:0002398) | 1.65353681 |
153 | Abnormality of the anterior horn cell (HP:0006802) | 1.65353681 |
154 | Distal arthrogryposis (HP:0005684) | 1.62706115 |
155 | Mitochondrial inheritance (HP:0001427) | 1.61884697 |
156 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.60169731 |
157 | Breast carcinoma (HP:0003002) | 1.59594514 |
158 | Pelvic girdle muscle weakness (HP:0003749) | 1.58640349 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 5.31560244 |
2 | NEK1 | 4.37077377 |
3 | PKN2 | 4.09693008 |
4 | PDK4 | 3.90791047 |
5 | PDK3 | 3.90791047 |
6 | TTN | 3.70360884 |
7 | OBSCN | 3.61676051 |
8 | TRIB3 | 2.80498582 |
9 | TRIM28 | 2.74609287 |
10 | PDK2 | 2.27241527 |
11 | EIF2AK1 | 2.10560489 |
12 | STK38L | 2.08000224 |
13 | NEK9 | 2.06894047 |
14 | FLT3 | 2.02633880 |
15 | SRPK1 | 1.92241653 |
16 | PNCK | 1.91034266 |
17 | PBK | 1.89224427 |
18 | MYLK | 1.87145155 |
19 | LMTK2 | 1.79251586 |
20 | STK39 | 1.74914596 |
21 | ZAK | 1.73746836 |
22 | FRK | 1.71772476 |
23 | PHKG1 | 1.69531267 |
24 | PHKG2 | 1.69531267 |
25 | MKNK2 | 1.66872794 |
26 | CCNB1 | 1.62891191 |
27 | STK24 | 1.59899332 |
28 | MST4 | 1.53427952 |
29 | SIK1 | 1.49251512 |
30 | BMPR1B | 1.45152776 |
31 | MUSK | 1.44858203 |
32 | PINK1 | 1.43874932 |
33 | FGFR4 | 1.40540510 |
34 | PIK3CA | 1.32280881 |
35 | MAP2K3 | 1.23300566 |
36 | CDC7 | 1.21696416 |
37 | ERBB4 | 1.21507607 |
38 | ATR | 1.19507257 |
39 | TTK | 1.19143900 |
40 | WEE1 | 1.17310180 |
41 | MAP3K12 | 1.17142282 |
42 | BCR | 1.16456842 |
43 | MKNK1 | 1.15818320 |
44 | CSNK1A1L | 1.11511386 |
45 | DMPK | 1.11272004 |
46 | CSNK1G3 | 1.07905843 |
47 | LATS1 | 1.06016813 |
48 | CSNK1G1 | 1.04708435 |
49 | ERN1 | 1.03051633 |
50 | STK4 | 1.02333411 |
51 | AKT3 | 0.94913973 |
52 | KDR | 0.94030612 |
53 | CDK4 | 0.91837793 |
54 | TSSK6 | 0.91569236 |
55 | RIPK1 | 0.90930996 |
56 | ACVR1B | 0.90720923 |
57 | BRD4 | 0.90143853 |
58 | NEK6 | 0.89102616 |
59 | MAPK11 | 0.88747822 |
60 | FER | 0.88001271 |
61 | CAMKK2 | 0.87822916 |
62 | EIF2AK2 | 0.85334771 |
63 | NEK2 | 0.84595699 |
64 | STK16 | 0.83279158 |
65 | MAP3K5 | 0.82427551 |
66 | BUB1 | 0.81864926 |
67 | CSNK1G2 | 0.81286660 |
68 | CHEK2 | 0.80405277 |
69 | ATM | 0.79757217 |
70 | MAP3K3 | 0.79606704 |
71 | MAP4K2 | 0.77948019 |
72 | NME2 | 0.77717363 |
73 | CHEK1 | 0.76410352 |
74 | MAP3K11 | 0.74203284 |
75 | NUAK1 | 0.72960326 |
76 | TIE1 | 0.71083041 |
77 | PRKAA1 | 0.70508037 |
78 | VRK1 | 0.69628632 |
79 | RAF1 | 0.69427497 |
80 | MAP3K8 | 0.69313242 |
81 | PLK4 | 0.68725347 |
82 | OXSR1 | 0.68111213 |
83 | MAP3K7 | 0.67698942 |
84 | PRKAA2 | 0.67558395 |
85 | PLK2 | 0.66545725 |
86 | CDK8 | 0.65793827 |
87 | PTK6 | 0.62351739 |
88 | BRSK1 | 0.60150682 |
89 | MAP3K9 | 0.60089440 |
90 | ILK | 0.59445613 |
91 | PDGFRA | 0.58651927 |
92 | MAP2K4 | 0.58583355 |
93 | TGFBR1 | 0.58304597 |
94 | STK3 | 0.58217347 |
95 | PIK3CG | 0.57982959 |
96 | ABL2 | 0.57927341 |
97 | AURKB | 0.57564462 |
98 | RPS6KA4 | 0.57559965 |
99 | LATS2 | 0.55520731 |
100 | AKT2 | 0.55500080 |
101 | RPS6KB2 | 0.53946223 |
102 | TRPM7 | 0.53351750 |
103 | CAMK2D | 0.52714805 |
104 | BRSK2 | 0.52436976 |
105 | TYK2 | 0.50138339 |
106 | MST1R | 0.48504046 |
107 | PAK3 | 0.48307339 |
108 | MAPK12 | 0.47420516 |
109 | LRRK2 | 0.47413196 |
110 | MAP3K10 | 0.47243524 |
111 | PRKACG | 0.46879180 |
112 | PRKCI | 0.46780835 |
113 | CDK1 | 0.46170253 |
114 | WNK4 | 0.46002815 |
115 | PLK1 | 0.45919779 |
116 | MTOR | 0.45530852 |
117 | MAPKAPK5 | 0.44483750 |
118 | INSRR | 0.44157572 |
119 | TAOK2 | 0.42687523 |
120 | CDK7 | 0.41931812 |
121 | CDK6 | 0.41357860 |
122 | CSNK1E | 0.40016478 |
123 | FGFR1 | 0.39701426 |
124 | MAPKAPK3 | 0.39249962 |
125 | RPS6KB1 | 0.39075932 |
126 | SCYL2 | 0.38318885 |
127 | CLK1 | 0.37649842 |
128 | KSR1 | 0.36946500 |
129 | STK10 | 0.36013695 |
130 | PIM2 | 0.35654625 |
131 | CAMK4 | 0.35629076 |
132 | JAK2 | 0.35614816 |
133 | PLK3 | 0.35052467 |
134 | PRKD1 | 0.35039771 |
135 | TAF1 | 0.34854887 |
136 | EEF2K | 0.34752678 |
137 | RPS6KA5 | 0.34728848 |
138 | PRKCE | 0.34477089 |
139 | PRKDC | 0.34401653 |
140 | PRKACB | 0.34253513 |
141 | CDK2 | 0.32834680 |
142 | SGK3 | 0.32022800 |
143 | ERBB3 | 0.31941979 |
144 | DAPK3 | 0.31650759 |
145 | ROCK1 | 0.28116090 |
146 | EIF2AK3 | 0.26127782 |
147 | WNK3 | 0.25696066 |
148 | ALK | 0.25175702 |
149 | CAMK2G | 0.25127795 |
150 | MAP2K1 | 0.23253812 |
151 | LIMK1 | 0.23050712 |
152 | STK38 | 0.22628676 |
153 | MET | 0.22515265 |
154 | NME1 | 0.22334969 |
155 | EPHA2 | 0.22045847 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.85883624 |
2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.68243533 |
3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.63974610 |
4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.18098258 |
5 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.15041673 |
6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.07502342 |
7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.93612969 |
8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.92401768 |
9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.54255585 |
10 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.47795315 |
11 | Carbon metabolism_Homo sapiens_hsa01200 | 2.47041663 |
12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.46419524 |
13 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.34534903 |
14 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.32566287 |
15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.22880344 |
16 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.20446732 |
17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.19899024 |
18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.16714390 |
19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.05499823 |
20 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.01746451 |
21 | Protein export_Homo sapiens_hsa03060 | 1.87202995 |
22 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.86598542 |
23 | Peroxisome_Homo sapiens_hsa04146 | 1.85308303 |
24 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.79314236 |
25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.78962495 |
26 | Homologous recombination_Homo sapiens_hsa03440 | 1.72783913 |
27 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.70662968 |
28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65462121 |
29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.61479496 |
30 | RNA degradation_Homo sapiens_hsa03018 | 1.60689423 |
31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.59806476 |
32 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.58003670 |
33 | Basal transcription factors_Homo sapiens_hsa03022 | 1.55870853 |
34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55755899 |
35 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.52395722 |
36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.52091013 |
37 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.51192486 |
38 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.46761030 |
39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.43599325 |
40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.40999511 |
41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.38249609 |
42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34549957 |
43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31750845 |
44 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.30529189 |
45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22832284 |
46 | RNA polymerase_Homo sapiens_hsa03020 | 1.21983175 |
47 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.20178009 |
48 | Spliceosome_Homo sapiens_hsa03040 | 1.18880565 |
49 | Cell cycle_Homo sapiens_hsa04110 | 1.13976641 |
50 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.13941314 |
51 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.05928409 |
52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.04973660 |
53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.03655928 |
54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02361861 |
55 | Bile secretion_Homo sapiens_hsa04976 | 1.00320375 |
56 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.97701287 |
57 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.97178069 |
58 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95968606 |
59 | Parkinsons disease_Homo sapiens_hsa05012 | 0.95731772 |
60 | Lysine degradation_Homo sapiens_hsa00310 | 0.94358182 |
61 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.90209157 |
62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.89106640 |
63 | Histidine metabolism_Homo sapiens_hsa00340 | 0.87733447 |
64 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85852062 |
65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.85156331 |
66 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84571395 |
67 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.83929530 |
68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.82746580 |
69 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.80336649 |
70 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.79754342 |
71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.79373445 |
72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.79210808 |
73 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.76498319 |
74 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.75328286 |
75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74993464 |
76 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73264277 |
77 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.72284411 |
78 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.71318376 |
79 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.69888326 |
80 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.68807455 |
81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66844087 |
82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65509151 |
83 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62700963 |
84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60307370 |
85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60136485 |
86 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58386196 |
87 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55618131 |
88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53031665 |
89 | ABC transporters_Homo sapiens_hsa02010 | 0.52124542 |
90 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51579665 |
91 | Huntingtons disease_Homo sapiens_hsa05016 | 0.51314240 |
92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.48314656 |
93 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47554157 |
94 | Insulin resistance_Homo sapiens_hsa04931 | 0.44913225 |
95 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43061706 |
96 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.41697778 |
97 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40544130 |
98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39501459 |
99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37827095 |
100 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37331315 |
101 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.36782084 |
102 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.35585071 |
103 | Proteasome_Homo sapiens_hsa03050 | 0.32458467 |
104 | DNA replication_Homo sapiens_hsa03030 | 0.31392824 |
105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.30036990 |
106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26223119 |
107 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.20568893 |
108 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.18008758 |
109 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.16121472 |
110 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.14418176 |
111 | Mismatch repair_Homo sapiens_hsa03430 | 0.12172030 |
112 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.11445041 |
113 | RNA transport_Homo sapiens_hsa03013 | 0.11078797 |
114 | Viral myocarditis_Homo sapiens_hsa05416 | 0.08994211 |
115 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.08250561 |
116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.03344783 |
117 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.02944333 |
118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.02550791 |
119 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.00941627 |
120 | Base excision repair_Homo sapiens_hsa03410 | -0.0639660 |
121 | Purine metabolism_Homo sapiens_hsa00230 | -0.0408649 |
122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.0320374 |